statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2024 after market close on Wednesday, August 7, 2024...

Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360 Test, Further Extending Its Best-in-Class Performance

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced the launch of a major upgrade to its market-leading Guardant360 liquid biopsy test. The new enhanced test...

Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors

Guardant Health, Inc. (NASDAQ:GH), a pioneer in precision oncology, today announced the appointment of Dr. Manuel Hidalgo Medina to its board of directors, effective immediately. Dr. Hidalgo...

Where Guardant Health Stands With Analysts

Latest Ratings for GH
 DateFirmActionFromTo Feb 2022Wells FargoMaintainsOverweight Feb 2022Morgan StanleyMaintainsOverweight Feb 2022CitigroupMaintainsBuy
 View More Analyst Ratings for GH...

American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond

American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond PR...

Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced the launch of a new version of its Guardant360 TissueNext test that expands the number of genes it identifies...

Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced its research collaborators from Washington Universitys Siteman Cancer Center will lead an oral presentation today...

Guardant Health Named to TIME100 Most Influential Companies

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced its inclusion in the fourth-annual TIME100 Most Influential Companies list, highlighting companies making an...

Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data from 16 studies highlighting the role of...

Evaluating Guardant Health: Insights From 5 Financial Analysts

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.

Volume	1.23M
52-Wk High	$41.06
52-Wk Low	$15.81

GH Guardant Health Inc

About

Feed

News

Sentiment

Earnings

Fundamentals